According to a recent real-world study, dupilumab is safe and efficacious in treating moderate-to-severe atopic dermatitis (AD) in pediatric patients.
top of page
it's where dermatology lives
bottom of page
According to a recent real-world study, dupilumab is safe and efficacious in treating moderate-to-severe atopic dermatitis (AD) in pediatric patients.
Comments